AAAndreas Antzoulas

Andreas Antzoulas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andreas Antzoulas has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Mental diseases in gastrointestinal cancer survivors: prevalence and impact on overall survival

    by Ejona Shaska Zilja, Andreas Antzoulas, Elias Liolis, Francesk Mulita

  • The current role of cryoablation in the management of soft tissue and bone tumors: A narrative review

    by Marios Platon Dimopoulos, Nefeli Chaniotaki, Maria Papageorgiou, Sylvain Bodard, Andreas Antzoulas, Francesk Mulita, Zafiria Papathanassiou, Leonidas Goudas, Panagiotis Kitrou, Dimitrios Karnabatidis, et al.


  • Laparoscopic management of a large hepatic Echinococcosis granulosus cyst with concurrent cholelithiasis

    by Christos Svoronos, Vasileios Leivaditis, Ting Vanessa Jane Chow, Elias Liolis, Levan Tchabashvili, Konstantinos Tasios, Andreas Antzoulas, Francesk Mulita

    Human echinococcosis (hydatidosis or hydatid) disease is a worldwide neglected zoonotic larval infection typically caused by cestodes of the Echinococcus genus. It affects 1 million people worldwide, predominantly reported in Central Asia, the Middle East, and South America. In this paper, we report a patient who underwent a successful laparoscopic partial pericystectomy and omentoplasty with simultaneous cholecystectomy in the treatment of cystic echinococcosis and cholelithiasis, respectively. There are many challenges to treating complicated hepatic hydatid cysts. It is crucial for surgeons to have knowledge of the range of possibilities of each surgical modality and its expanding advancements that can reduce complication risks and increase a patient’s quality of life. The art of sharing techniques and management possibilities between professionals in this field provides a bridge in further crafting the best-tailored treatment plan for patients. This report illustrates the successful usage of laparoscopy in the management of a section IV hydatid cyst with simultaneous cholecystectomy. This case aims to expand the knowledge and prospects of laparoscopic surgery in cystic echinococcosis.

  • Open Access

    Pain Scales: Types and Comparison

    by Emiljan Mustaqe, Elias Liolis, Eleni Bekou, Levan Tchabashvili, Konstantinos Tasios, Andreas Antzoulas, Dimitrios Litsas, Panagiotis Leventis, Viola Tzafai, Platon Dimopoulos, et al.

    Objective: Pain is a common and significant symptom in clinical practice, particularly among emergency and cancer patients. This article explores various pain scales and their clinical applications, alongside postoperative pain management in oncologic patients. A review of unidimensional pain scales, including the Numeric Rating Scale (NRS), Visual Analog Scale (VAS), Verbal Rating Scale (VRS), and Faces Pain Rating Scale (FPS), is presented. Additionally, the pathophysiology and pharmacological and non-pharmacological strategies for managing postoperative pain in cancer patients are discussed. Pain scales vary in sensitivity, ease of use, and clinical suitability. NRS is widely preferred for its simplicity and statistical applicability, whereas VAS offers higher sensitivity but practical limitations. Postoperative pain in oncologic patients is influenced by surgical trauma, psychological factors, and pre-existing pain conditions, with inadequate management leading to systemic complications and increased cancer recurrence risk. Effective management incorporates both non-opioid and opioid analgesics based on pain severity. Pain assessment tools and effective management strategies are critical for improving patient outcomes in clinical settings. Tailored approaches, particularly in oncologic postoperative care, can mitigate complications and enhance quality of life.


  • Open Access

    Costs of Inflammatory markers worldwide and the use of Butyrylcholinesterase (BChE)

    by Emiljan Mustaqe, Elias Liolis, Eleni Bekou, Levan Tchabashvili, Konstantinos Tasios, Andreas Antzoulas, Dimitrios Litsas, Panagiotis Leventis, Viola Tzafai, Platon Dimopoulos, et al.

    Objective: Butyrylcholinesterase (BChE) is an enzyme that shares similarities with acetylcholinesterase (AChE) but has been less studied due to its uncertain physiological role. Initially regarded as an ‘orphan enzyme,’ recent studies suggest that BChE plays a significant role in inflammation, primarily through its involvement in the cholinergic anti-inflammatory pathway. This enzyme, primarily produced by the liver, is found in several tissues and is known to hydrolyze acetylcholine, a neurotransmitter that modulates immune responses. BChE levels are influenced by various diseases, such as diabetes, cardiovascular diseases, and neurological disorders, which are associated with inflammation. This study reviews the costs of inflammatory biomarkers worldwide and investigates the association between BChE and inflammation. Data from multiple countries reveal varying costs for biomarkers like C-reactive protein (CRP), procalcitonin (PCT), and BChE, with BChE being a more cost-effective option in certain regions such as Greece and Armenia. Furthermore, BChE activity correlates inversely with the degree of systemic inflammation, and its levels may serve as a predictive marker for conditions such as surgical infections and anastomotic leaks. The findings underscore the potential of BChE as a useful and affordable biomarker for monitoring inflammation, particularly in settings where other biomarkers are more costly. However, further research is needed to validate its widespread clinical application.